Clinical Trial

Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study

Completed Phase 2
View on ClinicalTrials.gov →
Summary
The Understanding and Addressing Rejection of Personalized Cancer Risk Information study is a longitudinal study conducted to understand the nature of phenomenon of personalized cancer risk rejection in the context of mammography screening.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-07; most recent amendment 2026-02-09.
Trial Details
NCT Number NCT06975085
Lead Sponsor University of Colorado, Denver
Collaborators: National Cancer Institute (NCI)
Conditions Breast Cancer Female
Enrollment 781 participants
Start Date 2025-04-16
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-03